Stories about research and scientific development at Mount Sinai
Mount Sinai Presents Groundbreaking Findings on Heart Procedure
In a groundbreaking, multi-centered randomized trial published in The New England Journal of Medicine, researchers, co-led by Mount Sinai’s David H. Adams, MD, determined that a catheter-based heart procedure to replace an aortic valve was superior to surgery for...
New Discoveries in Triple-Negative Breast Cancer
Two newly identified proteins that appear to play a critical role in the development of aggressive triple-negative breast cancer (TNBC) could also lead to potential new treatments, according to scientists at Icahn School of Medicine at Mount Sinai, the University of...
Genetic Research Leading to Advances in Autism Care
Autism spectrum disorder (ASD) describes a group of neurodevelopmental disorders with a wide range of severity and symptoms affecting 1 out of 68 children in the United States. While there is currently no medicine for this complex condition, discovering genetic causes...
Mount Sinai Scientists Appear on CBS This Morning
In February, CBS This Morning had a segment on Mount Sinai’s novel use of fruit flies to screen for personalized cancer drugs. Ross Cagan, PhD, Associate Dean of the Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, discussed how his...
New Findings from Mount Sinai’s Seaver Autism Center
The most recent study from the Seaver Autism Center at Mount Sinai draws a possible link between the genetic abnormalities attributed to autism spectrum disorder (ASD), and dysregulation of the mechanism by which unused neural connections are pruned during...
Studying the Effect of Vitamin E on Functional Decline in Alzheimer’s Disease
Functional decline, measured as the loss of ability to accomplish activities of daily living, such as bathing and dressing, planning or cooking a meal, and paying bills, is the major symptom in individuals with Alzheimer’s disease and the primary source of caregiver...
New Discoveries Shed Light on Schizophrenia
Rare mutations in specific sets of genes may increase one’s chances of developing schizophrenia, according to investigators at Icahn School of Medicine at Mount Sinai, who recently led one of the largest and most comprehensive exome-sequencing studies of the...
Neurology Research Residency Program
Sam Horng, MD, PhD, and PGY3 resident in the Department of Neurology has been approved for funding under the Mount Sinai R25 Research Residency Program. The Program provides mentoring and dedicated time set aside for research during residency and fellowship years. Dr....
Blazing a New Trail in the Treatment of Heart Disease
An injectable nanoparticle that delivers HMG-CoA reductase inhibitors, or statins, which directly inhibit atherosclerotic plaque inflammation could represent a new frontier in the treatment of heart disease. This novel approach is being developed by researchers at...